Blue Owl Capital (NYSE:OBDC – Get Free Report) had its price objective reduced by equities research analysts at Keefe, Bruyette & Woods from $14.50 to $13.50 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “market perform” rating on the stock. Keefe, Bruyette & Woods’ price target would indicate a potential upside of 12.55% from the stock’s previous close.
OBDC has been the topic of several other reports. Zacks Research lowered shares of Blue Owl Capital from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 21st. Raymond James Financial set a $14.00 price target on shares of Blue Owl Capital and gave the company an “outperform” rating in a report on Tuesday, October 7th. Citizens Jmp cut their price objective on shares of Blue Owl Capital from $17.00 to $15.00 and set a “market outperform” rating for the company in a research report on Friday. Wells Fargo & Company decreased their target price on Blue Owl Capital from $13.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Friday. Finally, LADENBURG THALM/SH SH raised Blue Owl Capital to a “strong-buy” rating in a report on Friday, August 8th. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Blue Owl Capital presently has an average rating of “Moderate Buy” and a consensus target price of $14.81.
Read Our Latest Analysis on OBDC
Blue Owl Capital Stock Performance
Blue Owl Capital (NYSE:OBDC – Get Free Report) last issued its earnings results on Wednesday, November 5th. The company reported $0.36 EPS for the quarter, missing the consensus estimate of $0.39 by ($0.03). Blue Owl Capital had a return on equity of 10.58% and a net margin of 36.89%.The business had revenue of $453.07 million for the quarter, compared to the consensus estimate of $466.81 million. Research analysts predict that Blue Owl Capital will post 1.71 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Hamilton Lane Advisors LLC acquired a new position in shares of Blue Owl Capital in the 2nd quarter valued at about $48,845,000. Graypoint LLC boosted its holdings in shares of Blue Owl Capital by 49.4% during the 2nd quarter. Graypoint LLC now owns 590,048 shares of the company’s stock worth $8,461,000 after buying an additional 194,999 shares in the last quarter. Kingstone Capital Partners Texas LLC bought a new position in shares of Blue Owl Capital during the 2nd quarter worth approximately $734,619,000. Integrated Wealth Concepts LLC grew its position in shares of Blue Owl Capital by 217.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 43,069 shares of the company’s stock worth $631,000 after buying an additional 29,521 shares during the period. Finally, Trinity Financial Advisors LLC grew its position in shares of Blue Owl Capital by 2.3% during the 2nd quarter. Trinity Financial Advisors LLC now owns 1,150,853 shares of the company’s stock worth $16,929,000 after buying an additional 25,377 shares during the period. Institutional investors and hedge funds own 42.83% of the company’s stock.
Blue Owl Capital Company Profile
Blue Owl Capital Corporation is a business development company. It specializes in direct and fund of fund investments. The fund makes investments in senior secured, direct lending or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments, first lien, unitranche, and second lien term loans and common equity investments.
Recommended Stories
- Five stocks we like better than Blue Owl Capital
- How to Use the MarketBeat Stock Screener
- An Earnings Win With a Stock Slump: What’s Happening With D-Wave?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Stocks Showing Relative Strength as Markets Pull Back
- Top Biotech Stocks: Exploring Innovation Opportunities
- 5 Defensive Consumer Plays to Watch If Markets Keep Slipping
Receive News & Ratings for Blue Owl Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Owl Capital and related companies with MarketBeat.com's FREE daily email newsletter.
